K Fukutake
Overview
Explore the profile of K Fukutake including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
180
Citations
354
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Inaba H, Shinozawa K, Fukutake K, Amano K
Haemophilia
. 2018 Jul;
24(4):e289-e292.
PMID: 30004147
No abstract available.
2.
Masaoka T, Amano K, Takedani H, Suzuki T, Otaki M, Seita I, et al.
Haemophilia
. 2016 Dec;
23(2):e116-e123.
PMID: 27943552
Introduction: Detecting signs of joint deterioration is important for early effective orthopaedic intervention in managing haemophilic arthropathy. Aim: We developed a simple, patient self-administered sheet to evaluate the joint condition,...
3.
Shinkoda Y, Shirahata A, Fukutake K, Takamatsu J, Shima M, Hanabusa H, et al.
Haemophilia
. 2016 Aug;
23(1):59-66.
PMID: 27480904
Introduction: MC710, a 1:10 protein weight ratio mixture of plasma-derived activated factor VII (FVIIa) and factor X (FX), is a novel bypassing agent for haemostasis in haemophilia patients with inhibitors....
4.
Nishida Y, Arai M, Yamamoto Y, Fukutake K
Haemophilia
. 2016 May;
3(2):137-42.
PMID: 27214724
Clotting factor concentrates prepared from human plasma are a potential route of parvovirus B19 (B19) infection in patients with coagulation disorders. However, it is not clear whether B19 transmits and...
5.
Hagiwara T, Fukue H, Kawata K, Yamagishi T, Yamamoto Y, Arai M, et al.
Haemophilia
. 2016 May;
2(2):104-8.
PMID: 27214017
Beta interferon therapy was given to seven chronic hepatitis C patients with haemophilia or other haemorrhagic disorders who had received clotting factor replacement therapy. Serum alanine aminotransferase (ALT) levels ranged...
6.
Takedani H, Shima M, Horikoshi Y, Koyama T, Fukutake K, Kuwahara M, et al.
Haemophilia
. 2014 Dec;
21(3):374-379.
PMID: 25521821
Patients with congenital haemophilia with inhibitors or acquired haemophilia are at risk of bleeding complications during surgery. In these patients, replacement therapy for the missing coagulation factor is ineffective, and...
7.
Shirahata A, Fukutake K, Takamatsu J, Shima M, Hanabusa H, Mugishima H, et al.
Haemophilia
. 2013 Jun;
19(6):853-60.
PMID: 23738888
MC710, a mixture of plasma-derived activated factor VII and factor X at a protein weight ratio of 1:10, is a novel bypassing agent for haemostasis in haemophilia patients with inhibitors....
8.
Shirahata A, Fukutake K, Mimaya J, Takamatsu J, Shima M, Hanabusa H, et al.
Haemophilia
. 2012 Sep;
19(2):330-7.
PMID: 22989180
We reported the results of a clinical pharmacological study of MC710 (a mixture of plasma-derived FVIIa and FX) in haemophilia patients with inhibitors during a non-haemorrhagic state. This report provides...
9.
Inaba H, Koyama T, Shinozawa K, Amano K, Fukutake K
Haemophilia
. 2012 Jul;
19(1):100-5.
PMID: 22776136
Haemophilia A is caused by various genetic mutations in the factor VIII gene (F8). However, after conventional analysis, no candidate mutation could be identified in the F8 of about 2%...
10.
Inaba H, Shinozawa K, Hagiwara T, Suzuki T, Yamamoto Y, Amano K, et al.
Haemophilia
. 2011 Dec;
18(2):e43-4.
PMID: 22176576
No abstract available.